Factors Associated with Pneumocystis jirovecii Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study
Conclusion Clinicians should pay close attention to patients with RA who possess risk factors for the development of PCP during MTX therapy.PMID:34511571 | DOI:10.2169/internalmedicine.8205-21
Source: Internal Medicine - Category: Internal Medicine Authors: Shin-Ichiro Ohmura Yoichiro Homma Takayuki Masui Toshiaki Miyamoto Source Type: research
More News: Arthritis | Internal Medicine | Methotrexate | Pneumonia | Prednisolone | Rheumatoid Arthritis | Rheumatology | Study